Drugs / GSK3206640A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01999842 | Nov 2013 → Feb 2014 | influenza | GlaxoSmithKline | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK3206640A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01999842 ↗ |